Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00045695 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: bortezomib

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]
[object Object]